Neostem (NBS +1.6%) agrees to sell 51% of its interest in Suzhou Erye Pharmaceutical, a...


Neostem (NBS +1.6%) agrees to sell 51% of its interest in Suzhou Erye Pharmaceutical, a China-based generic pharmaceutical company, for $12.3M in cash. Included in the agreement is the the return to the company of 1.04M shares of common stock and the cancellation of 1.17M options and 640K common stock warrants, which collectively represent 1.3% of NBS' outstanding shares.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs